Selnick Jesse 4
4 · Sight Sciences, Inc. · Filed Jul 19, 2021
Insider Transaction Report
Form 4
Selnick Jesse
Chief Financial Officer
Transactions
- Conversion
Series B Redeemable Convertible Preferred Stock
2021-07-19−118,494→ 0 total(indirect: See footnote)→ Common Stock (236,988 underlying) - Conversion
Common Stock
2021-07-19+2,219,568→ 2,219,568 total(indirect: See footnote) - Conversion
Series A Redeemable Convertible Preferred Stock
2021-07-19−869,565→ 0 total(indirect: See footnote)→ Common Stock (1,739,130 underlying) - Conversion
Series C Redeemable Convertible Preferred Stock
2021-07-19−121,725→ 0 total(indirect: See footnote)→ Common Stock (243,450 underlying)
Footnotes (2)
- [F1]The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering.
- [F2]These shares are held of record by Sight Sciences Angels, LP ("Sight Sciences Angels"). The reporting person is a Managing Member of the General Partner of Sight Sciences Angels and may be deemed to beneficially own the shares of common stock held by Sight Sciences Angels.